YONSEI UNIVERSITY

Their core work

Yonsei University is one of South Korea's top private research universities, with departments spanning medicine, natural sciences, engineering, and information technology. In H2020, their contributions reflect this breadth: TB vaccine development, multimedia network quality management, Arctic climate research, and ultrafast optics in condensed matter physics. Their participation as a non-EU partner and third party indicates they bring specialized Asian research capabilities and infrastructure that European consortia specifically seek out.

What they specialise in

How they've shifted over time

Yonsei's early H2020 involvement (2015-2018) centred on health (TB vaccines) and ICT (multimedia quality of experience), reflecting established departments contributing to large European networks. Their later projects (2016-2021) shifted toward fundamental physical sciences — Arctic climate systems and ultrafast optics — suggesting growing engagement of their physics and earth science faculties with European research. However, with only four projects across very different domains, this likely reflects independent departmental participation rather than a deliberate institutional shift.

Yonsei's H2020 engagement appears opportunistic across departments rather than strategically focused, so future collaboration depends on identifying the right faculty group rather than expecting institutional direction.

How they like to work

Yonsei has never coordinated an H2020 project, always joining as a participant or third party — consistent with the role of a non-EU institution that brings complementary expertise to European-led consortia. Their 96 unique partners across 23 countries from just 4 projects indicate involvement in large, multi-partner consortia rather than tight bilateral collaborations. This suggests they are sought after for specific capabilities rather than being a consortium-building hub.

Despite only 4 projects, Yonsei has worked with 96 distinct partners across 23 countries, reflecting participation in very large international consortia. Their network spans broadly across Europe with no single geographic concentration.

What sets them apart

As a leading South Korean university, Yonsei offers European consortia access to Asian research infrastructure, clinical populations, and regional scientific networks that most EU partners cannot provide. Their multi-disciplinary breadth means different faculties can be tapped for very different project needs. For consortium builders needing a credible East Asian partner with proven H2020 experience, Yonsei is a tested choice.

Highlights from their portfolio

• TBVAC2020
  Large-scale global TB vaccine consortium — Yonsei's involvement signals strong biomedical research capacity and access to Asian clinical contexts.
• Blue-Action
  Major Arctic climate project running 5 years (2016-2021), the longest of Yonsei's H2020 engagements, indicating sustained commitment to climate science collaboration.